LONDON, May 17, 2019 /PRNewswire/ -- Ampersand Health and Crohn's & Colitis UK today announce a joint initiative to enable people with Inflammatory Bowel Disease (IBD) to take an active role in ...

The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn's disease has identified a genetic marker which could individualise drug treatment. A ...

There's positive news for those suffering from Crohn's disease, as a new treatment has been approved in the UK, according to an NHS doctor. Crohn's disease is a long-term condition where part of the ...

A budding racing driver from Derbyshire wants to show that having Crohn's disease is not going to stop him from achieving his goals. George Foxlow from Bradbourne, near Ashbourne, had major surgery to ...

Crohn's disease is an inflammatory condition of the digestive tract that continues to puzzle medical professionals. What it ...

Scientists are investigating whether stem cells could be used to 're-boot' the immune system and provide a cure for Crohn's Disease. A major clinical trial is been launched to find out whether stem ...

A common misconception surrounding Crohn’s disease is that it’s much the same as irritable bowel syndrome (IBS). But while symptoms are similar, the conditions are very different. Crohn’s is one of ...

A woman who missed out on her teenage years as she battled undiagnosed Crohn’s disease spent months in an eating disorder inpatient unit before her diagnosis, and needed 60cm of her bowel removed ...

Important Disclosure: The content provided does not consider your particular circumstances and does not constitute personal advice. Some of the products promoted are from our affiliate partners from ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Crohn's Disease Market and Competitive Landscape Highlights - 2016" report to their offering. The latest ...

A genetic variant carried by 40% of the population explains why some patients develop antibodies against the anti-TNF drugs, infliximab and adalimumab and lose response. The authors conclude that a ...